Dilated cardiomyopathy in retrovirally infected mice: A novel model for silent viral DCM?

Cardiovascular Toxicology

Volumn 4, Issue 4, 2004, Pages 317-325

  Beischel, Julie ^a   Larson, Douglas F ^a,c   Yu, Qianli ^a,b   Yang, Bo ^a   Sepúlveda, Ramon Tomas ^b   Kelley, Tara ^a   Watson, Ronald R ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b Arizona Prevention Center   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Dilated cardiomyopathy; Murine acquired immunodeficiency syndrome; Viral myocarditis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GENOMIC DNA; INDUCIBLE NITRIC OXIDE SYNTHASE; RNA; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; COMPETITIVE POLYMERASE CHAIN REACTION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE PRESSURE; IMMUNOHISTOCHEMISTRY; MOUSE; MURINE ACQUIRED IMMUNE DEFICIENCY SYNDROME; MURINE LEUKEMIA VIRUS; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; VIRUS DETECTION; VIRUS INFECTION; VIRUS MYOCARDITIS;

ANIMALS; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; DNA, VIRAL; FEMALE; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; MYOCARDITIS; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RETROVIRIDAE; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

ALPHAVIRUS; ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 9244258623     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:4:4:317     Document Type: Article

References (35)

1. American Heart Association. (2002). Heart Disease and Stroke Statistics-2003 Update. American Heart Association, Dallas, TX.
2. Towbin, J.A. and Bowles, N.B. (2000). Genetic abnormalities responsible for dilated cardiomyopathy. Curr. Cardiol. Rep. 2:475-480.
3. Bachinski, L.L. and Roberts, R. (1998). New theories: causes of dilated cardiomyopathy. Cardiol. Clin. 16:603-610.
4. Mestroni, L., Rocco, C., Vatta, M., Miocic, S., and Giacca, M. (1998). Advances in molecular genetics of dilated cardiomyopathy. Cardiol. Clin. 16:611-621.
5. Kearney, M.T., Cotton, J.M., Richardson, P.J., and Shah, A.M. (2001). Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgrad. Med. J. 77:4-10.
6. Gluck, B., Schmidtke, M., Merkle, L, Stelzner, A., and Gemsa, D. (2001). Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice. J. Mol. Cell. Cardiol. 33:1615-1626.
7. Habib, F.M., Springall, D.R., Davies, G.J., Oakley, C.M., Yacoub, M.H., and Polak, J.M. (1996). Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347:1151-1155.
8. Lipshultz, S.E. (1998). Dilated cardiomyopathy in HIV-infected patients. N. Engl. J. Med. 339:1153-1155.
9. Barbara, G. and Lipshultz, S.E. (2001). Pathogenesis of HIV-associated cardiomyopathy. Ann. NY Acad. Sci. 946: 57-81.
10. Fisher, S.D. and Lipshultz, S.E. (2001). Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann. NY Acad. Sci. 946:13-22.
11. d'Amati, G., di Gioia, C.R., and Gallo, P. (2001). Pathological findings of HIV-associated cardiovascular disease. Ann. NY Acad. Sci. 946:23-45.
12. Barbara, G., Di Lorenzo, G., Grisorio, B., and Barbarini, G. (1998). Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N. Engl. J. Med. 339:1093-1099.
13. Anderson, D.W., Virmani, R., Reilly, J.M., O'Leary, T., Cunnion, R.E., Robinowitz, M., et al. (1988). Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J. Am. Coll. Cardiol. 11:792-799.
14. Himelman, R.B., Chung, W.S., Chernoff, D.N., Schiller, N.B., and Hollander, H. (1989). Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J. Am. Coll. Cardiol. 13: 1030-1036.
15. Cohen, I.S., Anderson, D.W., Virmani, R., Reen, B.M., Macher, A.M., Sennesh, J., et al. (1986). Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N. Engl. J. Med. 315:628-630.
16. Barbara, G. (2001). Cardiovascular manifestations of HIV infection. J. R. Soc. Med. 94:384-390.
17. Felker, G.M., Thompson, R.E., Hare, J.M., Hruban, R.H., Clemetson, D.E., Howard, D.L., et al. (2000). Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 342:1077-1084.
18. Barbara, G., Di Lorenzo, G., Soldini, M., Giancaspro, G., Grisorio, B., Pellicelli, A., et al. (1999). Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA). Circulation 100:933-939.
19. Chattopadhyay, S.K., Sengupta, D.N., Fredrickson, T.N., Morse, H.C. 3rd, and Hartley, J.W. (1991). Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. J. Virol. 65: 4232-4241.
20. Liang, B., Wang, J.Y., and Watson, R.R. (1996). Murine AIDS, a key to understanding retrovirus-induced immunodeficiency. Viral Immunol. 9:225-239.
21. Opie, L.H. (1998). The Heart: Physiology, from Cell to Circulation. Lippincott-Raven Publishers, Philadelphia.
22. Sepulveda, RT., Jiang, S., Beischel, J., Bellamy, W.T., and Watson, R.R. (2000). Cocaine injection and coxsackie B3 infection increase heart disease during murine AIDS. J. Acquir. Immune Defic. Syndr. 25(Suppl. 1):S19-S26.
23. Yang, B., Larson, D.F., Beischel, J., Kelly, R., Shi, J., and Watson, R.R. (2001). Validation of conductance catheter system for quantification of murine pressure-volume loops. J. Invest. Surg. 14:341-355.
24. Glower, D.D., Spratt, J.A., Snow, N.D., Kabas, J.S., Davis, J.W., Olsen, C.O., et al. (1985). Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 71:994-1009.
25. Kass, D.A., Yamazaki, T., Burkhoff, D., Maughan, W.L., and Sagawa, K. (1986). Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation 73:586-595.
26. Casabianca, A., Vallanti, G., and Magnani, M. (1998). Competitive PCR for quantification of BM5d proviral DNA in mice with AIDS. J. Clin. Microbiol. 36:2371-2374.
27. Sanderson, J.E. (1997). Diastolic heart failure and the extracellular matrix. Int. J. Cardiol. 62(Suppl. 1):S19-S21.
28. Parrillo, J.E., Aretz, H.T., Palacios, I., Fallon, J.T., and Block, P.C. (1984). The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure: endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation 69:93-101.
29. Di Somma, S., Marotta, M., Salvatore, G., Cudemo, G., Cuda, G., De Vivo, F., et al. (2000). Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans. Heart 84:659-667.
30. Tyagi, S.C., Kumar, S., Voelker, D.J., Reddy, H.K., Janicki, J.S., and Curtis, J.J. (1996). Differential gene expression of extracellular matrix components in dilated cardiomyopathy. J. Cell. Biochem. 63:185-198.
31. Weiss, L.M., Liu, X.F., Chang, K.L., and Billingham, M.E. (1992). Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues. J. Clin. Invest. 90:156-159.
32. Klingel, K., Hohenadl, C., Canu, A., Albrecht, M., Seemann, M., Mall, G., et al. (1992). Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA 89:314-318.
33. Obrador, D., Ballester, M., Carrio, I., Auge, J.M., Lopez, C.M., Bosch, I., et al. (1993). Active myocardial damage without attending inflammatory response in dilated cardiomyopathy. J. Am. Coll. Cardiol. 21:1667-1671.
34. Elliott, P. (2000). Cardiomyopathy: diagnosis and management of dilated cardiomyopathy. Heart 84:106-112.
35. Manolio, T.A., Baughman, K.L., Rodeheffer, R., Pearson, T.A., Bristow, J.D., Michels, V.V., et al. (1992). Prevalence and etiology of idiopathic dilated cardiomyopathy. Am. J. Cardiol. 69:1458-1466.